Take steps to start getting relief
from noninfectious HIV-related diarrhea
Understand that you are not alone. In a survey of adults living with HIV,
Understand that you are not alone. In a survey of adults living with HIV,
27%
were currently
experiencing diarrhea
27%
were currently experiencing diarrhea
61%
with a history of diarrhea had experienced it for >1 year1,*
*Type of diarrhea was unspecified.
61%
with a history of diarrhea had experienced it for >1 year1,*
*Type of diarrhea was unspecified.
You deserve relief.
Talk to a doctor about Mytesi today.
Telehealth is an easy way to talk to a healthcare professional without having to wait for your next annual visit.
Flexible
Choose a time that is convenient for you.
Private
Talk to a doctor about your concerns from the privacy and comfort of any location you choose.
Low Cost
Your healthcare consult will only cost $30. If the doctor thinks Mytesi is a medically appropriate option, eligible commercially insured patients may pay as little as $0.
Learn how Mytesi may offer relief
You don’t have to accept chronic diarrhea as your norm.
Mytesi may be able to help.
You don’t have to accept chronic diarrhea as your norm.
Mytesi may be able to help.
Mytesi is the only FDA-approved antidiarrheal that can provide long-term relief from noninfectious, HIV-related diarrhea in adults living with HIV on ART.2
Support with accessing Mytesi
References: 1. Online Survey of Patients Living with HIV (2017). Sponsored by Napo Pharmaceuticals. 2. Mytesi [package insert]. San Francisco, CA: Napo Pharmaceuticals (2018).
